DrugJun 7, 2023
Akorn Granisetron HCl Injection, USP, 1 mg/mL recall — FDA D-0806-2023
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Class IIFDA: OngoingAkorn, Inc.
10,685drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 63
10,685 detailed records are currently available in this category.
DrugJun 7, 2023
Akorn Midazolam Injection, USP 2mg/2mL (1 mg/mL) For Intramuscular or Intravenous Use Only recall — FDA D-0828-2023
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Class IIFDA: OngoingAkorn, Inc.
DrugJun 7, 2023
Akorn Lidocaine Ointment USP, 5%, 1 1/4 oz tubes recall — FDA D-0822-2023
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Class IIFDA: OngoingAkorn, Inc.
DrugJun 7, 2023
Akorn Midazolam Injection, USP, 50 mg/10mL (5mg/mL), For Intramuscular or Intravenous Use recall — FDA D-0859-2023
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Class IIFDA: OngoingAkorn, Inc.
DrugJun 7, 2023
Akorn Calcipotriene Topical Solution, 0.005% (Scalp Solution), 60 mL bottles recall — FDA D-0789-2023
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Class IIFDA: OngoingAkorn, Inc.
DrugJun 7, 2023
Akorn Timolol Maleate Ophthalmic Solution, USP 0.5% recall — FDA D-0849-2023
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Class IIFDA: OngoingAkorn, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services vasopressin 20 units added to 0.9% sodium chloride 100 recall — FDA D-0747-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, Maintenance 4:1 recall — FDA D-0667-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (Trophamine) recall — FDA D-0684-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, Warm Induction 4:1 HIGH recall — FDA D-0655-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services MSA 7.84% MSG 8.56% (0.92M) Comp recall — FDA D-0750-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services vancomycin added to 0.9% sodium chloride, 2 g/500 mL* recall — FDA D-0723-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services diphenhydrAMINE 50 mg added to 0.9% sodium chloride 50 recall — FDA D-0738-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, Induction 8:1 non-enriched, HIGH recall — FDA D-0678-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services potassium phosphate 30 mmole added to 0.9% sodium recall — FDA D-0728-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services NORepinephrine added to dextrose 5%, 16 mg/250 mL* recall — FDA D-0743-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (Trophamine) recall — FDA D-0700-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (Trophamine) recall — FDA D-0696-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, Maintenance 4:1 in Ringer's, low recall — FDA D-0671-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services EPINEPHrine added to 0.9% sodium chloride, 4 mg/250 mL* recall — FDA D-0742-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (Trophamine) recall — FDA D-0691-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (Trophamine) recall — FDA D-0694-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, Induction 8:1 High Potassium/low recall — FDA D-0665-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugMay 31, 2023
Central Admixture Pharmacy Services vancomycin added to 0.9% sodium chloride, 1.5 g/250 mL* recall — FDA D-0722-2023
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.